$3.97 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
-Total revenue in the last quarter.
-Net income is all revenues minus all expenses including taxes and interest in the last quarter.
$-0.56Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-103.41xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
-Earnings before interest expenses and taxes in the last quarter.
394The number of full time employees.
Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.
Is it going to be inflation or deflation? The two schools of thought are poles apart in their thesis of what effect central bank interventions will have.Seeking Alpha, about 2 months ago
Schrodinger Inc. (NASDAQ: SDGR) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Ramy Farid -- President, Chief Executive Officer and BoardAlphaStreet, 2 months ago
By Michael Dabaie Schrodinger Inc. said it is in a strategic collaboration with Thermo Fisher Scientific to extend the use of cryo-electron microscopy in connection with in silico compound… | June ...MarketScreener, 4 months ago